GLMD icon

Galmed Pharmaceuticals

18 hedge funds and large institutions have $3.14M invested in Galmed Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$1.4M 316,016 +142,500 +82%
PWAM
2
Park West Asset Management
California
$912K 205,500
PAWC
3
P.A.W. Capital
Connecticut
$266K 60,000 +60,000 New
SKK
4
Shepherd Kaplan Krochuk
Massachusetts
$142K 31,990
VKH
5
Virtu KCG Holdings
New York
$73K 16,512 +16,512 New
WJA
6
Williams Jones & Associates
New York
$67K 15,000 +5,000 +50%
MC
7
Menta Capital
California
$65K 14,707 -3,441 -19%
CA
8
CapWealth Advisors
Tennessee
$53K 12,000
CS
9
Credit Suisse
Switzerland
$49K 11,000 +11,000 New
Morgan Stanley
10
Morgan Stanley
New York
$43K 9,486 +4,635 +96%
Wells Fargo
11
Wells Fargo
California
$33K 7,500 +7,500 New
UBS Group
12
UBS Group
Switzerland
$17K 3,787 +3,787 New
EDRE
13
Edmond de Rothschild (Europe)
Luxembourg
$4K 916
EDRH
14
Edmond de Rothschild Holding
Switzerland
$4K 916
Bank of America
15
Bank of America
North Carolina
$2K 460
RFA
16
Reilly Financial Advisors
California
$1K 250
AIM
17
Acrospire Investment Management
Illinois
$1K 200 +200 New
KCM
18
Knoll Capital Management
Florida
-49,947 Closed
CAD
19
Craig A. Drill
-20,000 Closed
Renaissance Technologies
20
Renaissance Technologies
New York
-10,900 Closed
Deutsche Bank
21
Deutsche Bank
Germany
-5,200 Closed
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
-5,176 Closed
TRCT
23
Tower Research Capital (TRC)
New York
$0 58 -250 -81%